Abstract：
The field of rare and diffuse pediatric lung disease continues to evolve and expand rapidly as clinicians and researchers make advancements in the diagnosis and treatment of children\'s interstitial and diffuse lung disease, non-cystic fibrosis bronchiectasis, and primary ciliary dyskinesia. Papers published on these topics in Pediatric Pulmonology and other journals in 2022 describe newly recognized disorders, elucidate disease mechanisms and courses, explore potential biomarkers, and assess novel treatments. In this review, we will discuss these important advancements and place them in the context of existing literature.
摘要：
随着临床医生和研究人员在儿童间质性和弥漫性肺疾病的诊断和治疗方面取得进展，罕见和弥漫性小儿肺部疾病领域继续发展并迅速扩大。非囊性纤维化支气管扩张,和原发性纤毛运动障碍。2022年在儿科肺病学和其他期刊上发表的关于这些主题的论文描述了新发现的疾病。阐明疾病机制和病程，探索潜在的生物标志物，并评估新的治疗方法。在这次审查中,我们将讨论这些重要的进步，并将它们放在现有文献的背景下。
